|

Skin Involvement in Dupuytren Surgical Treatment Outcome

RECRUITINGN/ASponsored by Universitaire Ziekenhuizen KU Leuven
Actively Recruiting
PhaseN/A
SponsorUniversitaire Ziekenhuizen KU Leuven
Started2024-12-10
Est. completion2027-01-01
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Palmar skin is often retracted in Dupuytren disease (DD), making surgical management challenging and skin-preserving surgery difficult. Based on clinical experience in DD surgery and outcome, it is suspected that recurrence may be associated with such retracted skin. Possibly, this is due to presence and persistence of aligned myofibroblasts (MF), fixed to the deepest dermal layers. This interventional study aims to investigate the pathophysiological involvement of palmar skin in Dupuytren disease, and its implications for prognostics and treatment.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures.
2. Patients ≥ 18 years old, diagnosed with primary Dupuytren disease.
3. Patients must be scheduled for microfasciectomy.

Exclusion Criteria:

1. Earlier Dupuytren surgery in the hand scheduled for microfasciectomy
2. Patient's unable to give a written participating consent.
3. Younger than 18 years of age.

Conditions2

CancerDupuytren Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.